Raloxifene – New contestant in COVID-19 treatment race

Raloxifene - COVID-19 (Coronavirus) treatment - South Korea

Among several drugs, Remdesivir and Hydroxychloroquine are the contestants in the drug trial race for the COVID-19 treatment.

Researchers in South Korea have identified a new drug for an effective treatment for COVID-19. The drug called Raloxifene is a medication used to prevent and treat osteoporosis in postmenopausal women and those on glucocorticoids.

Gyeonggi Business and Science Accelerator and the National Institute of Health in South Korea have identified that the drug raloxifene can hinder COVID-19 activities at the cell level. However, further clinical trials will be required for confirmation and declaration of raloxifene as a drug for COVID-19 treatment.

The Ministry of Food and Drug Safety, South Korea will take decision on continuing the drug for the human trial.

The details are based on Arirang News.

Arirang news - Raloxifene - COVID-19 (Coronavirus) treatment - South Korea


Comments

Popular posts from this blog

42 Postdoctoral Researcher Positions, South Korea - KRICT Recruitment_94602 - July 2020

9 Researcher and Postdoctoral researcher jobs - Ulsan Institute of Science and Technology (UNIST), South Korea

3 Postdoctoral Positions - Materials Science & Engineering, KAIST, South Korea (Deadline:July 13, 2020)

122 Internship Positions - KRICT, South Korea - Intern recruitment_94628 - July 2020

Researchers Job available at 3D Bioprinting Research Center, Korea Polytechnic University, South Korea (Deadline: July 31, 2020)

Alternative Indian apps for the banned apps in India – 59 digital apps banned in India

Bubonic plague in China, another epidemic warning sign in 2020

Sushant Singh Rajput - a young Indian actor, and dancer ends his life by hanging in his home

New Swine Flu – G4 EA H1N1 – What to know? Facts around G4 EA H1N1